Condition: Heart Failure · Sponsor: Novo Nordisk A/S
This study will look into how CDR132L (a potential new medicine) works on the structure and function of the heart in people living with heart failure. Participants will either get CDR132L or placebo (a medicine which has no effect on the body), which treatment the participants get is decided by chance. The study will last for about 60 weeks.
This description comes directly from the study's public registry record.
Novo Nordisk · (+1) 866-867-7178 · clinicaltrials@novonordisk.com
Always discuss trial participation with your own doctor first.
| Univ of Alabama Birmingham | Birmingham, Alabama, United States | Recruiting |
| TMC Hlthcr Clin Res Office | Tucson, Arizona, United States | Not Yet Recruiting |
| Pima Heart and Vascular | Tucson, Arizona, United States | Not Yet Recruiting |
| Valley Clinical Trials | Covina, California, United States | Recruiting |
| UCSD NAFLD Research Center | La Jolla, California, United States | Recruiting |
| Valley Clinical Trials | Northridge, California, United States | Recruiting |
| University of California, San Francisco | San Francisco, California, United States | Recruiting |
| University of California San Francisco UCSF | San Francisco, California, United States | Recruiting |
| Harbor-UCLA Medical Center | Torrance, California, United States | Recruiting |
| Univ of Colorado at Denver | Aurora, Colorado, United States | Not Yet Recruiting |
| Inpatient Research Clinic LLC | Miami Lakes, Florida, United States | Recruiting |
| AdventHealth Orlando | Orlando, Florida, United States | Not Yet Recruiting |
+ 103 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06979362